Loading...

/News/RNS

Cancellation - Amryt Pharma plc

RNS Announcement

RNS Number : 9648X

AIM

11 January 2022

NOTICE

11/01/2022 - 07:00

NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM

Pursuant to AIM Rule 41 the following securities have been cancelled from trading on AIM with effect from the time and date of this notice.

AMRYT PHARMA PLC
213800YNUJEOJ84L4T95
ORDINARY SHARES OF 6P EACH, FULLY PAID	(BKLTQ41)(GB00BKLTQ412)	AMRT PHAR/PAR VTG FPD 0.06

If you have any queries or require further information, please contact the company's nominated adviser.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

AMOFLFVVLIIILIF

RNS metadata

Title: Cancellation - Amryt Pharma plc
Time: 07:00:06
Date: 11 Jan 2022
Category: Corporate updates
ID: 9648X